Knight Therapeutics buy krebskrebs
Start price
30.11.20
/
50%
€3.50
Target price
30.11.21
€4.00
Performance (%)
5.14%
End price
01.12.21
€3.68
Summary
This prediction ended on 01.12.21 with a price of €3.68. With a performance of 5.14%, the BUY prediction by krebskrebs for Knight Therapeutics closed with a slight gain. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Knight Therapeutics | 4.386% | 4.386% | 51.786% | 94.444% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by krebskrebs for this prediction
In the thread Knight Therapeutics diskutieren
In the thread Trading Knight Therapeutics
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten